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Two new isolates of bovine lentivirus, also known as bovine immunodeficiency-like virus (BIV), were obtained 
from a seropositive cattle herd in Florida. This is the first report of new isolates of BIV since the original BIV 
strain, R29, was isolated in 1%9. The two new BIV isolates were derived from blood butFy coat cells cocultivated 
in vitro with fetal bovine lung cell cultures. The new isolates differed in vitro from the original R29 isolate in 
replication and syncytium formation in fetal bovine lung cells. Both new isolates were confirmed as BIV by 
immunofluorescence assay, Western blotting (immunoblotting), and polymerase chain reaction. Sequence 
analyses of the polymerase chain reaction pol gene product showed 92.6 and 93.670 homology to the published 
nucleotide sequence of BIV R29-127, a molecular clone derived from BIV R29. Each of the new BIV isolates was 
inoculated into two calves, and virus was recovered between 5 and 10 days postinoculation (p.i.), with BIV 
seroconversion between 10 and 21 days p.i. V i s  was recoverable and antibody was detectable for at least 4 
months p.i. Two calves developed a transiently elevated mononuclear cell count, similar to what was reported for 
BIV R29 in the original experimental calf inoculations. No other clinical abnormalities were observed. 
The original isolation of the bovine immunodeficiency-like lostrum-deprived calves induced mild lymphocytosis and 
virus (BIV) was made in 1969 from an &year-old dairy cow enlargement of peripheral subcutaneous lymph nodes, with 
from Louisiana that had a persistent lymphocytosis and was no overt clinical signs of disease (28). In recent studies with 
becoming progressively emaciated. At the time of necropsy, (i) BIV R29-1203 inoculant free of BVDV, (ii) R29 inoculant 
this cow had clinical and histopathological lesions, including in BVDV-vaccinated cattle, or (iii) BIV R29-106 molecular 
perivascular cuffing in some vessels in the brain and enlarged clone inoculant, the original experimental findings of leuko- 
lymph nodes and hema1 nodes (28). The viral isolate from cytosis and lymph node enlargement have not been ob- 
this dairy cow, designated R29, was originally described as a served, suggesting that the virus has become attenuated (6, 
visna-like virus because of similarities to the ovine lentivi- 10). Attenuation of lentiviruses in cell cultures has been 
ruse With the finding that human immunodeficiency virus described in detail for equine infectious anemia virus (5, 25). 
type 1 (HIV-1) is a lentivirus, renewed interest in the bovine However, the virulence of one equine infectious anemia 
visna-like virus resulted in its molecular characterization, virus isolate was increased with rapid animal passage (25). 
which conclusively placed BIV in the lentivirus family as a similar experiments with BIV have not resulted in a change 
unique member of the group (4, 10, 11). in the course of infection. The BIV R29-106 molecular clone, BIV causes a persistent infection in cattle, and serological is infectious for cell cultures in vitro, was not sus- data id icate  that it may have a prevalence ( 2 ~  3, tained by animal passage through whole-blood transfer (6, 13, 14, 29, 30). BIV has a genomic organization similar to 10). 
that of other lentiviruses, including thepol,gag, env, and tat 
~,,,,,1 studies with BIV have explored the possibility genes (lo, 24). Antigenically, antiserum to BIV P~~ cross- that this virus causes immune system alterations, similar to 
reacts with p24 of HIV-1 and antiserum to equine infectious HIV-l or feline immunodeficiency virus. However, because 
anemia virus cross-reacts with P~~ and P~~ of BIV ('9 31). the original BIV isolate, R29, has become contaminated with Two infectious molecular clones of BIV R29, BIV R29-127 
a noncytopathic strain of BVDV, an RNA virus that can 
and BIV '29-106 have been sequenced, showing that the 
cause immune suppression in bovines, interpretation of data 
virus is a unique member of the lentivirus (4, lo). BIV acquired from cattle inoculated with this isolate has become R29-106, however, did not replicate well in cattle after 
complicated (6, 21). studies examining immune function of 
experimental inoculation (6). BIV in vivo have demonstrated either mild or no immuno- All molecular characterizations and animal inoculation suppression on the basis of lymphocyte blastogenesis tests, 
studies of BIV have been done with the BIV R29 
neutrophil function tests, mononuclear subset analysis, and isolate, which has been passaged in vitro Or histopathological ,-hanges (6, 8, 21). Available research for Over 20 years, and it may be attenuated (6, '9 lo). 
results have not shown that BIV is a disease-causing agent in 
The R29 has become amtaminated with a cattle in experimental inoculations. These reports were all 
nOncytO~athic strain of bovine diarrhea virus (BVDV). based on studies of cattle infected for less than 27 months (6, The original experimental inoculations of BIV R29 in co- 8, 28-30). Thus, the Dossibilitv that BIV has a long 
Corresponding author. 
incubation period before causing disease or that it has the 
ability to act as a cofactor in disease cannot been ruled out 
(6, 29). 
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In this report, we describe the in vitro and in vivo 
characterization of two new wild-type isolates of BIV which 
were isolated from two cows in a seropositive dairy herd in 
Florida. A BVDV-free BIV isolate of R29, BIV R29-1203, 
was also used in this study as a positive control to help 
contrast the differences between the new isolates and R29- 
derived isolates. The R29-1203 isolate was prepared by 
vaccinating a BIV-BVDV-negative calf with an autogenous 
BVDV vaccine prepared (S. R. Bolin, National Animal 
Disease Center, Ames, Iowa) from a clone of the noncyto- 
pathic BVDV isolated from BIV R29 cell cultures. After the 
calf developed neutralizing antibodies to BVDV, it was 
inoculated with BIV R29. BIV was recovered from blood 
buEy coat cells, tested both in vitro by cell culture methods 
and in vivo by calf inoculation, found to be free of BVDV, 
and designated BIV R29-1203. 
In vitm characterization of BIV isolates. A Florida dairy 
herd with BIV-seropositive cattle was identified by Western 
blot (immunoblot) assay, and blood samples in EDTA tubes 
were taken for virus isolation (31). The blood samples were 
centrifuged, and the buEy coat cells were removed for 
coculture with fetal bovine lung cells cultured in Eagle's 
minimum essential medium with Earle's salts supplemented 
with 10% fetal bovine serum, Polybrene (4 pg/ml), genta- 
micin (50 pg/ml), and 0.02% L-glutamine. These cultures 
were blind passaged and/or cultured with fresh fetal bovine 
lung cell cultures until the cytopathic effects of syncytium 
formation and cell lysis were observed. Evidence of viral 
replication by syncytium formation was observed in two 
cultures, FL491 and FL112, after the fourth blind passage in 
culture. The two cows from which the isolates were derived 
were seropositive for BIV on Western blot assay and sero- 
positive for bovine leukemia virus (BLV) and seronegative 
for bovine syncytial virus (BSV) on agar gel immunodifision 
(AGID) (19, 22, 31). Continued culturing of FLA91 and 
FL112 gave increased syncytium formation with limited cell 
lysis. The new isolates showed differences in replication 
characteristics in vitro compared with BIV R29, including 
higher cocultivation ratios, longer incubation times between 
passages, and differences in &cytial appearance typified by 
a decreased number of nuclei per syncytium and greater 
granularity and slower lysis of {he s$c$ia cornparid with 
BIV R29 and BIV R29-derived isolates. Syncytial nuclei 
from the new wild-type isolates often formed a circular 
pattern in culture which was not commonly observed in BIV 
R29-derived cultures. The BIV R29-1203 isolate demon- 
strated higher cytopathogenicity in cell culture than did the 
new isolates. The FL491 and FL112 wild-type isolates had 
similar replication patterns in vitro with smaller syncytia and 
a less lytic effect on cell cultures. The replication character- 
istics of the different BIV isolates were maintained in rela- 
tion to their parent strain after animal inoculation. 
The new wild-type isolates of BIV have biological differ- 
ences in comparison with R29 in vitro, and in vitro charac- 
teristics of other lentiviruses have been shown to correlate 
with virulence in vivo (7). Specifically, the more cytopatho- 
genic lentiviral strains in culture are associated with greater 
in vivo virulence in HIV-1 and greater lymphoproliferative 
change in the ovine lentivirus maedi-visna virus (7, 12, 16, 
17). Different regions of the viral genomes have been asso- 
ciated with these in vitro and in vivo characteristics (9, 12, 
23,32). Biological variation should not be unexpected among 
BIV isolates, and these differences are probably controlled 
by several different areas of the genome. 
FL491 and FL112 were BIV positive by immunofluores- 
cence assay using BIV-specific antiserum and fluorescein- 
NG. 1. Products of PCR amplification (left) of a 242-bp segment 
of the pol gene from BIV R29-1203 (lanes l) ,  BIV FLA91 (lanes 2), 
and BIV FL112 (lanes 3) and Southern blot hybridization (right) of 
those products with a 32P-labeledpol gene probe. Negative (lanes 4) 
and positive (lanes 5) PCR controls and a molecular size ladder are 
also shown. 
conjugated rabbit anti-bovine immunoglobulin G, but both 
isolates were indirect immunofluorescence assay negative 
for BLV and BSV by the same technique (30). Western blot 
assays using viral antigen prepared as previously described 
(31) from each of the isolates with positive reference control 
sera were positive for BIV, negative for BLV, and negative 
for BSV. AGID tests using positive reference sera for BLV 
and BSV were negative (data not shown) (19, 22). DNA 
samples for polymerase chain reactions (PCR) were pre- 
pared from BIV-infected fetal bovine lung cell cultures with 
proteinase K followed by phenol-chloroform extraction by 
standard procedures (20). One microgram of template DNA, 
20 pmol of primer, and 1.25 U of Tag polymerase (Cetus 
Corp., Norwalk, Conn.) in a 50-p1 reaction mixture were 
used in a standard PCR mixture with first-cycle conditions of 
94°C for 2 min, 51°C for 15 s, and 72°C for 2 min and then 30 
cycles of 94°C for 45 s, 51°C for 15 s, and 72°C for 1 min and 
a final extension step of 72°C for 10 min. The pol gene 
plus-sense primer 5' ATG CTA ATG GAT TIT AGG GA 3' 
and the minus-sense primer 5' CAT CCT TGT GGT AGA 
ACA TT 3' amplified a 242-bp product from BIV R29-1203-, 
FL491-, and FL112-infected cell cultures (Fig. 1) whose size 
was predicted by published sequence data and previously 
reported work (10, 15). Southern blot analyses with the BIV 
pol gene-specific probe confirmed the identities of the PCR 
products (20). Each PCR product was then directly se- 
quenced by purification with a Centricon 100 microconcen- 
trator and use of 40 ng of DNA with Tag polymerase in a dye 
terminator sequencing system on an automated sequencer 
(ABI Applied Biochemistry 373A DNA Sequencer; per- 
formed at the Nucleic Acid Center, Iowa State University, 
Ames). Nucleotide sequences were analyzed for homology 
by using the Wilbur-Lipman methods (DNASTAR program 
Align). The 212-bp sequenced PCR products were compared 
to the published sequence for the putative reverse tran- 
scriptase gene segment of BIV R29-derived molecular clone 
BIV R29-127 (10). The BIV R29-1203 isolate had 99.6% 
nucleotide sequence homology with the published sequence, 
with only a single, silent nucleotide substitution. The BIV 
FL491 and FL112 isolates had 93.6 and 92.6% nucleotide 
sequence homology, respectively, to the published BIV 
sequence and 96% nucleotide sequence homology with each 
other. All of the sequenced products maintained the same 
open reading frame for a segment of the putative reverse 
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transcriptase gene, and no insertions or deletions were seen 
in the sequenced product. The predicted amino acid homol- 
ogies for BIV FL491 and FL112 were 93.8 and 92.3%, 
respectively. 
The reverse transcriptase region of the genome is highly 
conserved among other lentiviruses, and it is expected that 
BIV is similar. Comparison of thepol gene region of the BIV 
R29-1203 isolate, which has been through an animal passage 
and over 35 passages in cell culture, to the published 
sequence for BIV R29-127, a molecular clone of BIV R29, 
demonstrated that BIV R29-1203 has only a single, silent 
nucleotide change from the published sequence. This sug- 
gests that this segment of the reverse transcriptase region 
may be highly conserved in BIV and provides a valuable 
guidepost for comparison of new isolates. The new Florida 
isolates have 7 to 8% nucleotide sequence divergence in the 
conserved pol segment compared with Louisiana BIV R29- 
127, demonstrating the divergence of these isolates from 
R29. The new isolates have only 4% nucleotide sequence 
divergence between them, suggesting that they are more 
closely related field isolates. Comparisons of different 
HIV-1, visna virus, and feline immunodeficiency virus iso- 
lates show that the diversity of nucleotide sequences of 
isolates generally is greatest when they are from geographi- 
cally distinct populations (1, 18, 26,27). In comparison with 
these three lentivirus groups, the new Florida BIV isolates 
appear to be distinct from the Louisiana isolate but are not as 
divergent as other geographically distinct lentivirus isolates. 
Sequencing of other BIV isolates will help to determine 
whether the Florida isolates are distinct or continuurns of the 
same BIV population. 
In vivo characterization of BIV isolates. Four calves nega- 
tive for antibodies to BIV, BLV, and BSV were experimen- 
tally inoculated with the FL491 and FL112 isolates. Each 
calf received BIV-infected fetal bovine lung cells and culture 
fluids intravenously in the jugular vein and subcutaneously 
in the area around the jugular vein as follows: BIV FL491, 
Jersey calf 1268 and Holstein calf 848; BIV FL112, Jersey 
calves 1275 and 1269. Calves were observed for clinical 
symptoms, and blood samples were taken at 3, 5, 7, 10, 14, 
21, and 28 days postinoculation ( p i )  for virus isolation, 
serology, and leukocyte (WBC) differential counts. Thereaf- 
ter, the calves were sampled weekly for serologic and WBC 
responses and every 2 to 4 weeks for virus isolation. 
All four calves developed BIV-specific antibody responses 
as determined by Western blot analysis. Results of Western 
blotting of serum samples from calf 1275 taken preinocula- 
tion, on p.i. day 35, and on p.i. day 91 and from calf 1268 
taken preinoculation, on p.i. day 35, and on p.i. day 105 are 
shown in Fig. 2B. Calves 1268 and 848, inoculated with BIV 
FL491, developed a BIV-specific serological response start- 
ing at p.i. days 10 and 20, and virus was recovered from 
samples starting on p.i. days 10 and 11, respectively. Calves 
1275 and 1269, inoculated with BIV FL112, both developed 
a BIV-specific serological response starting at p.i. day 14, 
and virus was isolated from samples by p.i. days 5 and 7, 
respectively. Viral antigens prepared from virus recovered 
from experimentally inoculated calves 1268 and 1275 were 
used in a Western blot (Fig. 2A) and were positive with BIV 
reference sera. Western blot antigens were also tested with 
both BLV and BSV reference sera and were negative (data 
not shown). 
The WBC response for calves 1275 and 1269, inoculated 
with FL112, showed transient leukocytosis consisting 
mainly of mononuclear cells (Fig. 3). The WBC response for 
calves 1268 and 848, inoculated with FL491, was slightly 
FIG. 2. (A) Western blot assay in which BIV reference serum 
was reacted with viral antigens prepared from BIV R29-1203 (lane 
l),  BIV FLQ91 (lane 2), an isolate of FL491 from calf 1268 (lane 3), 
BIV FL112 (lane 4), and an isolate of FL112 from calf 1275 (lane 5). 
Molecular weight markers (MWM) are indicated on the left in 
thousands. (B) Western blot assays of serum samples from calf 1268, 
which had been inoculated with BIV FL491, taken preinoculation 
(lane I), on day 35 p.i. (lane 2), and on day 105 p.i. (lane 3) and 
serum samples from calf 1275, which had been inoculated with BIV 
FL112, taken preinoculation (lane 4), on day 35 p.i. (lane 5), and on 
day 91 p.i. (lane 6). Molecular weight markers are shown on the left. 
The 20-kDa band in pre- and postinoculation serum samples from 
both calves is not BIV specific. 
increased, with an increased percentage of mononuclear 
cells, but remained within the normal range (Fig. 3). The 
calves had the expected prescapular lymph node enlarge- 
ment on the side on which the inoculation materials were 
injected but showed no other clinical symptoms. 
Preinoculation sera from all calves were negative for 
neutralizing antibodies to BVDV, BLV, and BSV, except for 
calf 848, which had neutralizing antibody to BVDV. After 
inoculation with BIV, the three BVDV-seronegative calves 
remained negative for virus-neutralizing antibodies to 
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FIG. 3. Comparison of mononuclear (Mono) and polymorphonu- 
clear (PMN) cell counts in two calves inoculated with BIV FL112 
(calves 1275 and 1269) or BIV FL.491 (calves 1268 and 848). Calves 
1275 and 1269 showed the greatest mononuclear cell increase, 
similar to the WBC increase reported in the original experimental 
inoculations with BIV R29 (31). No changes in the polymorphonu- 
clear cell population were observed for either calf. 
BVDV. AGID tests for antibodies to BLV and BSV also 
remained negative for multiple samples taken from all calves 
from weeks 7 through 14 p.i. 
The new isolates in experimental inoculations caused a 
leukocytosis similar to that described in the original experi- 
mental inoculations with BIV (28). More cattle need to be 
inoculated to confirm the initial finding that these new 
isolates cause leukocytosis, to rule out the possibility of 
biological variation among cattle. These studies may provide 
further insight into the question of possible attenuation of the 
BIV R29 isolate and verify that BIV does cause leukocyto- 
sis. Results from the current study, as well as from future 
studies performed with these new wild-type isolates, should 
provide a clearer picture of the true effect of experimental 
inoculation with BIV. 
In conclusion, this study provides information on the 
biological and genetic characteristics of BIV and provides 
new BIV isolates for experimental study. Since it is possible 
that the original BIV R2Y isolate was attenuated through 
multiple cell culture passages, these new, low-passage, 
contaminant-free isolates will allow measurements of possi- 
ble immune suppression in vivo that may more accurately 
reflect a natural infection. The new isolates of BIV are 
important for continued investigation of the pathogenesis of 
BIV infections and elucidation of the potential role of BIV as 
a disease agent or a cofactor in disdase. The new isolates 
increase the potential value of BIV as an animal model for 
lentivirus infections. 
Nucleotide sequence accession numbers. The GenBank ac- 
cession numbers for the nucleotide sequences reported here 
are LO6524 (BIV FL112), LO6525 (BIV FL491), and LO6526 
(BIV R29-1203). 
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